[
    [
        {
            "time": "2023-10-15",
            "original_text": "Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Momentum Stock",
                    "Buy"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-15",
            "original_text": "The Zacks Analyst Blog Highlights: Verizon, Eli Lilly, Accenture, VMware and Schwab",
            "features": {
                "keywords": [
                    "Zacks Analyst Blog",
                    "Eli Lilly",
                    "Verizon",
                    "Accenture",
                    "VMware",
                    "Schwab"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "diverse sectors"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "The Zacks Analyst Blog Highlights: Verizon, Eli Lilly, Accenture, VMware and Schwab",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-15",
            "original_text": "See what the IHS Markit Score report has to say about Eli Lilly and Co.",
            "features": {
                "keywords": [
                    "IHS Markit Score",
                    "Eli Lilly"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "See what the IHS Markit Score report has to say about Eli Lilly and Co.",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-15",
            "original_text": "Today's Research Reports on Trending Tickers: Eli Lilly and Company and AstraZeneca",
            "features": {
                "keywords": [
                    "Research Reports",
                    "Trending Tickers",
                    "Eli Lilly",
                    "AstraZeneca"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Today's Research Reports on Trending Tickers: Eli Lilly and Company and AstraZeneca",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-15",
            "original_text": "Incyte (INCY) Announces Positive Data on Jakafi for GVHD",
            "features": {
                "keywords": [
                    "Incyte",
                    "Positive Data",
                    "Jakafi",
                    "GVHD"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Incyte (INCY) Announces Positive Data on Jakafi for GVHD",
                "Correlation": 2,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]